NCT01470001View on ClinicalTrials.gov

The Effect of Solifenacin on Post Void Dribbling in Women

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Post-micturition IncontinenceIncontinence
Interventions
DRUG

solifenacin

patient will receive solifenacin 5mg daily or placebo daily

Trial Locations (1)

53792

UW Hospital and Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT01470001 - The Effect of Solifenacin on Post Void Dribbling in Women | Biotech Hunter | Biotech Hunter